InvestorsHub Logo
Followers 785
Posts 128093
Boards Moderated 9
Alias Born 09/26/2011

Re: None

Thursday, 02/19/2015 9:08:46 AM

Thursday, February 19, 2015 9:08:46 AM

Post# of 4885
Big news this morning again!!! Groupe Athena, Inc. Issues Update on Atorvastatin Calcium Project

http://finance.yahoo.com/news/groupe-athena-inc-issues-atorvastatin-131500521.html

MUMBAI, IN / ACCESSWIRE / February 19, 2015 / Groupe Athena, Inc. (GATA) (GATA) announced today that the company has started Pharmacokinetic (PK) modeling as part of its preclinical studies in its continuing efforts to start production of Atorvastatin Calcium. Pharmacokinetic modeling is a mathematical technique for predicting the effect and efficacy of drug dosing over time. Broadly speaking, pharmacokinetic models describe how the body reacts to a drug in terms of absorption, distribution, metabolism, and excretion.

As announced earlier, based on current orders in hand, the company expects to achieve total revenues of $70 million in the current fiscal. The company is on track to report revenue of $16.5 million for the current quarter, which would reflect a growth 14% over the corresponding quarter of the previous year.

As was previously stated, the Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.